Neonatal and young infant sepsis by Group B Streptococci and Escherichia coli: a single-center retrospective analysis in Germany-GBS screening implementation gaps and reduction in antibiotic resistance
Open Access
- 1 November 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in European Journal of Pediatrics
- Vol. 179 (11), 1769-1777
- https://doi.org/10.1007/s00431-020-03659-8
Abstract
The last nationwide surveillance study on neonatal and young infant sepsis due to Group B Streptococci (GBS) and Escherichia coli in Germany was conducted between 2009 and 2010. The aim of this study is to provide longitudinal epidemiological data on neonatal and young infant sepsis caused by GBS and E. coli to reevaluate existing data and to inform clinical decision-making. Every positive blood culture for GBS and E. coli within the first 90 days of life that occurred at our center from 2008 until 2018 was identified. The epidemiological, clinical, laboratory, and microbiological data of all affected patients were analyzed through retrospective chart review, along with the pathogen's antimicrobial susceptibility results. In total, 106 episodes of neonatal sepsis were described; 31% (n = 33) being caused by GBS and 69% (n = 73) by E. coli; 87% of GBS early-onset disease (EOD) cases did not receive intrapartum antibiotic prophylaxis (IAP). Contrary to general trends, the proportion of resistant E. coli isolates decreased for all tested antibiotics over time. Coincidentally, antenatal antibiotic use beyond IAP during that period decreased significantly in our center. Conclusions: (1) Data at our center suggests at least a regional implementation gap in GBS screening and IAP. (2) The decline in the resistance rate of E. coli for all antimicrobial substances might indicate that the reduction of prenatal antibiotics use is beneficial and that neonatal antibiotic stewardship programs should include pregnant women as well.What is Known:center dot GBS screening and intrapartum antibiotic prophylaxis led to a 32%-reduction in GBS disease in Germany with a 0.75 (92:122) ratio of early-onset disease to late-onset disease in 2009-2010.center dot Prenatal antibiotic use might increase the risk of E. coli early-onset disease and antibiotic resistances.What is New:center dot The GBS early-onset disease rates were twice as high as those of late-onset disease, the ratio was 1.75 (21:12) in 2008-2018 at our institution. This suggests that there are at least regional implementation gaps in the antenatal GBS screening in Germany.center dot We found a decline in E. coli resistance rates over time for all antimicrobial substances. Reduction in use of prenatal antibiotics might be an explanation.Funding Information
- Technische Universität Dresden
This publication has 23 references indexed in Scilit:
- Implementation and impact of pediatric antimicrobial stewardship programs: a systematic scoping reviewAntimicrobial Resistance & Infection Control, 2020
- Intrapartum Antibiotic Chemoprophylaxis Policies for the Prevention of Group B Streptococcal Disease Worldwide: Systematic ReviewClinical Infectious Diseases, 2017
- A new antibiotic regimen treats and prevents intra-amniotic inflammation/infection in patients with preterm PROMThe Journal of Maternal-Fetal & Neonatal Medicine, 2015
- Group B streptococcus neonatal invasive infections, France 2007–2012Clinical Microbiology & Infection, 2015
- Trends in antibiotic resistance over time among pathogens from Canadian hospitals: results of the CANWARD study 2007-11Journal of Antimicrobial Chemotherapy, 2013
- Antibiotic susceptibility profiles of neonatal invasive isolates of Escherichia coli from a 2-year nationwide surveillance study in Germany, 2009–2010European Journal of Clinical Microbiology & Infectious Diseases, 2013
- Epidemiologie invasiver Infektionen durch Escherichia coli bei Neugeborenen und jungen Säuglingen in Deutschland – Aktuelle Ergebnisse der laufenden ESPED-StudieKlinische Padiatrie, 2010
- Ten years of KISS: The most important requirements for successJournal of Hospital Infection, 2008
- Changing Patterns in NeonatalEscherichia coliSepsis and Ampicillin Resistance in the Era of Intrapartum Antibiotic ProphylaxisPEDIATRICS, 2008
- Neonatal group B streptococcal disease: Incidence, presentation, and mortalityThe Journal of Maternal-Fetal & Neonatal Medicine, 2008